Physician profile
Edward Evans
NPI 1083799985
$36,374.36
in general payments reported to CMS, 2019-2025
48 companies · $1,928 in 2025
The $1,928 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $3,944 · 2021: $6,824 · 2022: $5,882 · 2023: $3,855 · 2024: $3,589 · 2025: $1,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,030 · Travel and Lodging: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,030.39 |
| Travel and Lodging | $342.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,583.64 | 2019-2025 | Aveir, Cardiomems |
| Medtronic, INC. | $4,720.81 | 2021-2024 | Micra, Abre, Endurant Iis |
| Biotronik INC. | $3,530.03 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Oscar |
| Astrazeneca Pharmaceuticals Lp | $3,437.50 | 2019-2025 | Farxiga, Lokelma |
| Medtronic Vascular, INC. | $1,955.21 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $1,912.60 | 2022-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $1,849.69 | 2019-2025 | |
| Amgen INC. | $1,370.76 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $1,159.71 | 2019-2024 | S-Icd System Magnet |
| Janssen Pharmaceuticals, INC | $932.46 | 2019-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $836.04 | 2021-2024 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $795.64 | 2019-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $778.51 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $562.13 | 2021-2025 | Ozempic, Wegovy |
| Merck Sharp & Dohme LLC | $424.44 | 2021-2025 | Verquvo |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $382.72 | 2022-2025 | |
| Atricure, INC. | $339.10 | 2023-2024 | |
| Angiodynamics, INC. | $331.20 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $257.93 | 2019-2022 | |
| Tactile Systems Technology INC | $252.57 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $223.11 | 2019-2025 | Eliquis, Camzyos |
| Abiomed | $216.51 | 2021-2025 | |
| Amarin Pharma, INC. | $188.76 | 2020-2021 | |
| Globus Medical, INC. | $157.03 | 2025 | Senza |
| Ekos Corporation | $124.91 | 2019 | |
| Beckman Coulter, INC. | $116.30 | 2019 | |
| Bardy Diagnostics, INC. | $90.00 | 2021-2022 | |
| Heartflow, INC. | $79.87 | 2023 | Ffrct |
| Esperion Therapeutics, INC. | $71.07 | 2020-2022 | |
| Chiesi USA, INC. | $63.01 | 2021 | |
| Medicomp INC | $62.18 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $56.44 | 2023-2024 | Inpefa |
| Cleerly, INC. | $44.39 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Edwards Lifesciences Corporation | $44.26 | 2020 | |
| Cardiovascular Systems INC. | $44.08 | 2019-2022 | |
| Inspire Medical Systems, INC. | $43.64 | 2024-2025 | Inspire |
| Acacia Pharma INC | $38.59 | 2021-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $37.94 | 2023 | Arcalyst |
| Biosense Webster, INC. | $37.86 | 2023 | Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $36.25 | 2024 | Arcalyst |
| Cvrx, INC. | $30.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $28.73 | 2019-2022 | |
| Cordis US Corp. | $25.28 | 2025 | |
| Recor Medical INC | $24.56 | 2024 | Paradise Renal Denervation System |
| Actelion Pharmaceuticals US, INC. | $24.40 | 2025 | Opsumit |
| Lundbeck LLC | $20.06 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.25 | 2022 | |
| Smith+Nephew, INC. | $15.19 | 2023 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.